Literature DB >> 3964740

Distinguishing among asthma, chronic bronchitis, and emphysema.

G L Snider.   

Abstract

The history holds the central role in distinguishing among asthma, chronic bronchitis, and emphysema. A personal or family history of atopy, a history of seasonal worsening of disease in response to a known environmental agent, perhaps seasonal, and marked variability in the severity of airflow obstruction, often with dramatic responsiveness to bronchodilator drugs, strongly support the diagnosis of asthma. Exacerbation of wheezing by exposure to cold air or following the ingestion of a drug, and asthma variants, such as nocturnal cough responsive to bronchodilator agents or exercise-induced asthma, all support the diagnosis of asthma. Peripheral blood eosinophilia or sputum eosinophilia support the diagnosis of asthma providing other known causes of eosinophilia can be excluded. Positive skin tests are helpful in establishing the atopic state and indicating its possible etiology. An elevated serum IgE level supports the diagnosis of asthma; a normal one does not exclude it. Cigarette smoking is a common background factor in both chronic bronchitis and emphysema, and both diseases are infrequently observed in the absence of this history. Long-standing mucous hypersecretion preceding airflow obstruction suggests the presence of chronic bronchitis. Progressive dyspnea on effort as the predominant symptom suggests the possibility of emphysema. Reversibility of airflow obstruction suggesting the presence of asthma can be obtained either from physical examination or serial pulmonary function studies. Apart from this, neither of these techniques is very useful in differential diagnosis. Evidence of emphysema in the chest roentgenogram and a low value of the Dco/VA are sensitive tests for the presence of emphysema but are not highly specific. The main value of making the differentiation among these three conditions now lies in establishing a prognosis and guiding the use of corticosteroid therapy. As new information accumulates on the pathogenesis, prevention, and treatment of asthma, chronic bronchitis, and emphysema, precise diagnosis is likely to acquire increased significance.

Entities:  

Mesh:

Year:  1985        PMID: 3964740     DOI: 10.1378/chest.87.1.35s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  How accurately can the parameters from a model of anisotropic 3He gas diffusion in lung acinar airways be estimated? Bayesian view.

Authors:  Alexander L Sukstanskii; G Larry Bretthorst; Yulin V Chang; Mark S Conradi; Dmitriy A Yablonskiy
Journal:  J Magn Reson       Date:  2006-10-09       Impact factor: 2.229

Review 2.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

3.  Prevalence of and risk factors for chronic bronchitis in a Canadian population: the Canadian Community Health Survey, 2007 to 2008.

Authors:  Chandima P Karunanayake; Briana Hagen; James A Dosman; Punam Pahwa
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

Review 4.  Understanding the effects of tobacco smoke on the pathogenesis of aortic aneurysm.

Authors:  Paul E Norman; John A Curci
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-16       Impact factor: 8.311

5.  Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers.

Authors:  Sonia Mesia-Vela; Chih-Ching Yeh; John H M Austin; Matthew Dounel; Charles A Powell; Anthony Reeves; Regina M Santella; Lori Stevenson; David Yankelevitz; R Graham Barr
Journal:  Biomarkers       Date:  2008-06       Impact factor: 2.658

6.  Characterization of a Mouse Model of Emphysema Induced by Multiple Instillations of Low-Dose Elastase.

Authors:  Milena V Oliveira; Soraia C Abreu; Gisele A Padilha; Nazareth N Rocha; Lígia A Maia; Christina M Takiya; Debora G Xisto; Bela Suki; Pedro L Silva; Patricia R M Rocco
Journal:  Front Physiol       Date:  2016-10-07       Impact factor: 4.566

7.  Prevalence and associated risk factors of chronic bronchitis in First Nations people.

Authors:  Punam Pahwa; Chandima P Karunanayake; Donna C Rennie; Joshua A Lawson; Vivian R Ramsden; Kathleen McMullin; P Jenny Gardipy; Judy MacDonald; Sylvia Abonyi; Jo-Ann Episkenew; James A Dosman
Journal:  BMC Pulm Med       Date:  2017-06-29       Impact factor: 3.317

Review 8.  Medication adherence issues in patients treated for COPD.

Authors:  Ruben D Restrepo; Melissa T Alvarez; Leonard D Wittnebel; Helen Sorenson; Richard Wettstein; David L Vines; Jennifer Sikkema-Ortiz; Donna D Gardner; Robert L Wilkins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

9.  The Effect of Bone Marrow Mononuclear Cells on Lung Regeneration and Apoptosis in a Simple Model of Pulmonary Emphysema.

Authors:  Mohammad K El-Badrawy; Nesrien M Shalabi; Mie A Mohamed; Amany Ragab; Heba Wagih Abdelwahab; Nahla Anber; Mohamed A Sobh; Yomna Khater; Aziza A Abdel Hamid
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.